New Irish tech to reduce last-minute chemo cancellations by 25%

A new digital tool called eAltra aims to reduce last-minute chemotherapy cancellations and improve outcomes for cancer patients. Founded by Denis Roche, eAltra is a web-based, AI-powered platform that helps triage patients before treatment, decreasing the chances of chemo session cancellations due to unexpected issues. Roche, with a background in technology in medical settings, launched eAltra after his previous venture, Vivartes.

Cancer treatment can be challenging, and last-minute cancellations are disheartening. Around 20% of treatments are canceled when patients are already at the hospital due to unforeseen problems. Good patient feedback, known as Patient-Reported Outcome Measures (Proms), is vital for understanding treatment impact. eAltra's conversational AI interface streamlines this process, making it easier for patients to communicate their health status.

Roche emphasizes the importance of patient engagement in symptom management for better outcomes. eAltra's system, developed with input from healthcare professionals, aims to enhance patient experience, reduce administrative burden, and increase patient throughput by up to 25%. The platform, accessible via smartphone, tablet, or browser, simplifies patient assessments before treatment, saving time for both patients and clinicians.

eAltra, a Trinity campus company, collaborates with healthcare institutions in Ireland and the UK. It is an Enterprise Ireland high potential start-up, having raised €1.4 million in funding. With plans for further expansion and piloting in hospitals, eAltra aims to revolutionize cancer care delivery.

According to the source: The Irish Times.